Summary
98.09 0.65(0.67%)05/09/2024
Cardinal Health, Inc. (CAH)
Cardinal Health, Inc. (CAH)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.23 | -3.18 | -8.84 | -5.53 | -3.08 | 19.96 | 137.86 | 15,991.75 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 99.83 | |
| Open | 98.77 | |
| High | 99.91 | |
| Low | 98.73 | |
| Volume | 1,774,330 | |
| Change | 1.21 | |
| Change % | 1.23 | |
| Avg Volume (20 Days) | 1,908,038 | |
| Volume/Avg Volume (20 Days) Ratio | 0.93 | |
| 52 Week Range | 80.90 - 116.04 | |
| Price vs 52 Week High | -13.97% | |
| Price vs 52 Week Low | 23.40% | |
| Range | 1.07 | |
| Gap Up/Down | -0.93 | |
Fundamentals | ||
| Market Capitalization (Mln) | 23,884 | |
| EBIDTA | 2,783,000,064 | |
| PE Ratio | 43.3894 | |
| PEG Ratio | 0.3086 | |
| WallStreet Target Price | 113.50 | |
| Book Value | -13.3810 | |
| Earnings Per Share | 2.2600 | |
| EPS Estimate Current Quarter | 1.9500 | |
| EPS Estimate Next Quarter | 1.8000 | |
| EPS Estimate Current Year | 7.3400 | |
| EPS Estimate Next Year | 7.5800 | |
| Diluted EPS (TTM) | 2.2600 | |
| Revenues | ||
| Profit Marging | 0.0025 | |
| Operating Marging (TTM) | 0.0107 | |
| Return on asset (TTM) | 0.0292 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 220,571,992,064 | |
| Revenue per share TTM | 891.2000 | |
| Quarterly Revenue Growth (YOY) | 0.0880 | |
| Quarterly Earnings Growth (YOY) | -0.2160 | |
| Gross Profit (TTM) | 6,545,000,000 | |
| Dividends | ||
| Dividend Share | 2.0020 | |
| Dividend Yield | 0.0206 | |
| Valuations | ||
| Trailing PE | 43.3894 | |
| Forward PE | 13.4953 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 16.0657 | |
| Revenue Enterprise Value | 0.1189 | |
| EBITDA Enterprise Value | 13.5813 | |
| Shares | ||
| Shares Outstanding | 243,567,008 | |
| Shares Float | 242,271,176 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.05 | |
| Insider (%) | 0.58 | |
| Institutions (%) | 90.23 | |
05/06 14:00 EST - InvestorPlace
3 Stocks to Give You Shelter From the Coming Market Crash
Sometimes the best offense is a good defense. In today's market, buying defensive stocks is probably one of the best strategies you can adopt to protect your portfolio's gains.
3 Stocks to Give You Shelter From the Coming Market Crash
Sometimes the best offense is a good defense. In today's market, buying defensive stocks is probably one of the best strategies you can adopt to protect your portfolio's gains.
05/06 10:01 EST - Zacks Investment Research
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
05/03 07:19 EST - MarketBeat
For Cardinal Health, the Proof Will be in Its Performance
Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. NYSE: CAH proved that investors can buy and sell the news.
For Cardinal Health, the Proof Will be in Its Performance
Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. NYSE: CAH proved that investors can buy and sell the news.
05/03 01:38 EST - Seeking Alpha
5 Expected Dividend Increases In May 2024
5 Expected Dividend Increases In May 2024
5 Expected Dividend Increases In May 2024
5 Expected Dividend Increases In May 2024
05/02 13:01 EST - Zacks Investment Research
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
05/02 12:17 EST - Seeking Alpha
Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH ) Q3 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Lisa Gill - JP Morgan Michael Cherny - Leerink Partners George Hill - Deutsche Bank Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Percher - Nephron Research Stephanie Davis - Barclays Eric Coldwell - Baird Elizabeth Anderson - Evercore ISI Stephen Baxter - Wells Fargo Lucas Romanski - TD Cowen Daniel Grosslight - Citi Operator Hello, and welcome to the Third Quarter Fiscal Year 2024 Cardinal Health Incorporated Earnings Conference Call. My name is George.
Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH ) Q3 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Lisa Gill - JP Morgan Michael Cherny - Leerink Partners George Hill - Deutsche Bank Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Percher - Nephron Research Stephanie Davis - Barclays Eric Coldwell - Baird Elizabeth Anderson - Evercore ISI Stephen Baxter - Wells Fargo Lucas Romanski - TD Cowen Daniel Grosslight - Citi Operator Hello, and welcome to the Third Quarter Fiscal Year 2024 Cardinal Health Incorporated Earnings Conference Call. My name is George.
05/02 08:52 EST - Reuters
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer.
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer.
05/02 07:08 EST - Market Watch
Cardinal Health's stock falls on mixed quarterly results
Cardinal Health Inc.'s shares CAH, -0.84% fell 1.2% premarket on Thursday after the company reported mixed results for its fiscal third quarter but raised its full-year profit outlook. The drug distributor and lab-equipment provider reported net income of $258 million, or $1.05 per share, down from $345 million, or $1.34 per share, in the year-earlier period.
Cardinal Health's stock falls on mixed quarterly results
Cardinal Health Inc.'s shares CAH, -0.84% fell 1.2% premarket on Thursday after the company reported mixed results for its fiscal third quarter but raised its full-year profit outlook. The drug distributor and lab-equipment provider reported net income of $258 million, or $1.05 per share, down from $345 million, or $1.34 per share, in the year-earlier period.
05/01 15:12 EST - InvestorPlace
Shhh! 3 Secret Retirement Stocks Flying Below Wall Street's Radar
Investing for retirement can be one of the most essential steps to securing a future of overall financial stability. Nowadays, many investors need to start preparing a nest egg at a young age despite the idea of retirement seeming unnecessary.
Shhh! 3 Secret Retirement Stocks Flying Below Wall Street's Radar
Investing for retirement can be one of the most essential steps to securing a future of overall financial stability. Nowadays, many investors need to start preparing a nest egg at a young age despite the idea of retirement seeming unnecessary.
04/29 13:10 EST - Zacks Investment Research
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
04/29 08:31 EST - Seeking Alpha
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
04/26 13:35 EST - Zacks Investment Research
Here's What You Should Know About EBAY Ahead of Q1 Earnings
EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.
Here's What You Should Know About EBAY Ahead of Q1 Earnings
EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.
04/26 12:31 EST - Zacks Investment Research
3 Medical Products Stocks Set to Beat This Earnings Season
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
3 Medical Products Stocks Set to Beat This Earnings Season
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
04/25 13:15 EST - Reuters
US FDA sends warning to Cardinal Health for marketing unapproved devices
The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
US FDA sends warning to Cardinal Health for marketing unapproved devices
The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
04/24 08:03 EST - InvestorPlace
A Repeat of 2022? 7 Defensive Stocks to Buy Before the Correction.
Are we headed for a repeat of 2022's brutal selloff? While no one can predict the future with certainty, current market trends are raising some ominous red flags.
A Repeat of 2022? 7 Defensive Stocks to Buy Before the Correction.
Are we headed for a repeat of 2022's brutal selloff? While no one can predict the future with certainty, current market trends are raising some ominous red flags.
04/23 18:56 EST - Zacks Investment Research
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
Cardinal Health (CAH) closed the most recent trading day at $103.37, moving +0.53% from the previous trading session.
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
Cardinal Health (CAH) closed the most recent trading day at $103.37, moving +0.53% from the previous trading session.
04/23 10:06 EST - Zacks Investment Research
Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?
Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?
Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
04/22 09:56 EST - Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
04/22 07:32 EST - Barrons
Cardinal Health Won't Renew OptumRx Distribution Pact. Guidance Is Unchanged.
The pharmaceutical distribution contract with OptumRx will expire in June.
Cardinal Health Won't Renew OptumRx Distribution Pact. Guidance Is Unchanged.
The pharmaceutical distribution contract with OptumRx will expire in June.
04/22 07:01 EST - Market Watch
Cardinal Health's stock slides 3.6% after announcing contract with OptumRx will not be renewed after end-June
Cardinal Health Inc. ‘s stock CAH, +2.07% fell 3.6% early Monday, after the pharmaceuticals distributor and medical lab products maker said its contracts with pharmacy benefits manager OptumRx will expire at the end of June and will not be renewed. The Dublin, Ohio-based company said it still expects 2024 EPS of $7.20 to $7.35 despite the end of the contract, which generated 16% of its revenue in fiscal 2023.
Cardinal Health's stock slides 3.6% after announcing contract with OptumRx will not be renewed after end-June
Cardinal Health Inc. ‘s stock CAH, +2.07% fell 3.6% early Monday, after the pharmaceuticals distributor and medical lab products maker said its contracts with pharmacy benefits manager OptumRx will expire at the end of June and will not be renewed. The Dublin, Ohio-based company said it still expects 2024 EPS of $7.20 to $7.35 despite the end of the contract, which generated 16% of its revenue in fiscal 2023.